Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.
What can federal health agencies do to revive the fading trust of the public?
Confidence in public health entities is spiraling downward in the U.S., and once-revered Washington institutions like the CDC and NIH are among the casualties in serious condition. How to break the negative momentum?
Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data
The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.
AAP, other physician societies double down on Kennedy-crossing vaccination stance
5 high-profile physician leaders: ‘Misinformation, politicization of commonsense public health efforts and sudden changes to federal vaccine guidance are creating mass confusion and diminishing trust in public health.’

‘Do-not-resuscitate’ orders for COVID-19 patients?

New findings highlight why a blanket “do-not-resuscitate” order for COVID-19 patients is not needed.

Selatogrel provides heart attack patients with a lightning-fast antiplatelet response

A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.

Stroke rates are low among COVID-19 patients—but when they occur, the risk of death is substantial

The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020.

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.

Biopharma may not come out on top from COVID-19 pandemic

While emerging conventional wisdom may state biopharmaceutical companies could see a boon as a result of the COVID-19 pandemic thanks to new treatment and vaccine opportunities, the sector may not come out on top.

New drug combination could lead to the return of an old diabetes treatment

Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.

The eye-opening connection between heart health and cognitive decline

The World Health Organization estimates that 82 million people will be affected by dementia by the year 2030—could maintaining a healthy heart be one way to keep such conditions at bay?

Testing nursing homes for COVID-19 costs $440M

Testing all residents and staff at the nation’s nursing homes just once would collectively cost $440 million, according to data from the American Health Care Association and National Center of Assisted Living (AHCA/NCAL).

Clinical

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

What can federal health agencies do to revive the fading trust of the public?

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

AAP, other physician societies double down on Kennedy-crossing vaccination stance